AstraZeneca's latest TV ad for Farxiga and kidney disease shows people living with diabetes and hypertension as potential targets.
January 20, 2023 02:56 PM ESTUpdated 03:53 PM
Pharma
Marketing

As­traZeneca ex­pands chron­ic kid­ney dis­ease 'Tar­get' cam­paign for Farx­i­ga

Beth Snyder Bulik

Senior Editor

In its lat­est com­mer­cial for Farx­i­ga, As­traZeneca prompts peo­ple to ask their doc­tor for their kid­ney num­bers. But what does that mean? It’s a pa­tient …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times